The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> November 9, 2016

Interview with the President, CEO and Co-Founder: Mauna Kea Technologies (OTCMKTS:MKEAY)

Loiseau, Sacha
Sacha Loiseau, Ph.D., is President, CEO and Co-Founder of Mauna Kea Technologies. Dr. Loiseau founded Mauna Kea Technologies in May 2000 and has been the CEO ever since. A co-inventor of the probe-based Confocal Laser Endomicroscopy technology,  he piloted the development of the Cellvizio product line, raising over 32 million euros with private investors until taking the company public in July 2011 on the NYSE Euronext Paris stock exchange. Mauna Kea's IPO enabled a capital raise of 56.5 million euros with new investors only and was the largest health care IPO in Europe in 2011. In 2013, Dr. Loiseau was named the co-lead of France's reindustrialization plan for medical devices by the French President and then a member of the Committee for the Future of Medicine. Dr. Loiseau started his career at the National Center for Space Studies in Toulouse and at the Paris Observatory, then joined NASA's Jet Propulsion Laboratory in Pasadena, California, as a research scientist. He is a graduate of the Ecole Polytechnique in Paris and has a Ph.D. in astrophysics and optical instrumentation. Dr. Loiseau is the author of multiple scientific articles and holds seven international patents. Profile
TWST: Can you describe Mauna Kea Technologies today and offer a very brief history?

Dr. Loiseau: Mauna Kea Technologies is a medical device company that has

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Profitability Strategy Pays Off for Bank IT Company Q2 Holdings
Three Mid-Cap Names Using Their Balance Sheets to Create Value
Look Beyond Traditional Emerging Markets for More Diversification, Less Risk
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy